Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer

NCT04887935 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Cancer of Prostate

Interventions

DRUG: Dapagliflozin

Sponsor

Washington University School of Medicine

Collaborators

[object Object]